• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-149 作为癌症的潜在分子靶点。

miR-149 as a Potential Molecular Target for Cancer.

机构信息

Department of Anatomy, National University of Singapore, Singapore.

出版信息

Curr Med Chem. 2018;25(9):1046-1054. doi: 10.2174/0929867324666170718102738.

DOI:10.2174/0929867324666170718102738
PMID:28721828
Abstract

BACKGROUND

MicroRNAs (miRNAs) are frequently dysregulated in cancers and serve as attractive targets for prognostication and therapeutic applications. Besides cancer, the biological functions of miR-149 have been studied in various diseases. This review aims to summarize the reports available in the literature, regarding miR-149 as a molecular target for cancer therapeutics.

METHODS

An extensive literature search was conducted using the Pubmed database to sieve out articles related to the roles of miR-149 in carcinogenesis and cancer progression, and potential miRNA-based therapies. A total of 89 publications were selected for inclusion in this review.

RESULTS

Depending on the cancer type, miR-149 can behave either as a tumor suppressor or as an 'onco-miR' that promotes tumorigenesis and cancer spread, suggesting that this miRNA has diverse functions. Potential miRNA-based therapies include the use of miRNA mimics, miRNA inhibitors, demethylating agents and circular RNAs.

CONCLUSION

Although targeting miRNA is an attractive anti-cancer strategy, not all cancers can be treated by the same miRNA-based strategy. A comprehensive understanding of miRNA regulatory mechanism is also necessary to improve the design of miRNA-based therapeutics and there is a need for safe and efficient delivery methods when using this approach for anti-cancer treatment.

摘要

背景

microRNAs(miRNAs)在癌症中经常失调,作为预后和治疗应用的有吸引力的靶标。除了癌症,miR-149 的生物学功能已在各种疾病中得到研究。本综述旨在总结文献中关于 miR-149 作为癌症治疗的分子靶标的报道。

方法

使用 Pubmed 数据库进行广泛的文献检索,以筛选出与 miR-149 在致癌和癌症进展中的作用以及潜在的 miRNA 治疗相关的文章。总共选择了 89 篇出版物纳入本综述。

结果

根据癌症类型的不同,miR-149 可以作为肿瘤抑制因子或促进肿瘤发生和癌症扩散的“癌 miRNA”发挥作用,表明该 miRNA 具有多种功能。潜在的 miRNA 治疗包括使用 miRNA 模拟物、miRNA 抑制剂、去甲基化剂和环状 RNA。

结论

尽管靶向 miRNA 是一种有吸引力的抗癌策略,但并非所有癌症都可以通过相同的基于 miRNA 的策略治疗。全面了解 miRNA 调控机制对于改善 miRNA 治疗的设计也是必要的,并且在使用这种方法进行抗癌治疗时需要安全有效的递送方法。

相似文献

1
miR-149 as a Potential Molecular Target for Cancer.miR-149 作为癌症的潜在分子靶点。
Curr Med Chem. 2018;25(9):1046-1054. doi: 10.2174/0929867324666170718102738.
2
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.DNA甲基化导致12种癌症相关微小RNA的失调及乳腺癌进展。
Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.
3
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.miR-155 在癌症药物耐药性中的作用及其作为 miRNA 为基础的治疗靶点。
Cancer Metastasis Rev. 2018 Mar;37(1):33-44. doi: 10.1007/s10555-017-9724-7.
4
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.miR-130a的表观遗传破坏通过靶向SEC23B和DEPDC1促进前列腺癌。
Cancer Lett. 2017 Jan 28;385:150-159. doi: 10.1016/j.canlet.2016.10.028. Epub 2016 Oct 27.
5
Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.与结直肠癌进展密切相关的微小RNA及其基因靶点的计算分析
Microrna. 2019;8(1):68-75. doi: 10.2174/2211536607666180803100246.
6
The therapeutic potential of microRNAs in cancer.微小 RNA 在癌症中的治疗潜力。
Cancer J. 2012 May-Jun;18(3):275-84. doi: 10.1097/PPO.0b013e318258b5d6.
7
Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.miR-100在癌症诊断、预后及治疗中的潜在作用。
Tumour Biol. 2015 Mar;36(3):1403-9. doi: 10.1007/s13277-015-3267-8. Epub 2015 Mar 5.
8
miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.miR-150、p53 蛋白和相关 miRNA 构成了 NSCLC 肿瘤发生中的调控网络。
Oncol Rep. 2013 Jul;30(1):492-8. doi: 10.3892/or.2013.2453. Epub 2013 May 13.
9
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.miR-660 在肺癌患者中表达下调,其替代物通过靶向 MDM2-p53 相互作用抑制肺肿瘤发生。
Cell Death Dis. 2014 Dec 11;5(12):e1564. doi: 10.1038/cddis.2014.507.
10
Role of microRNAs in endocrine cancer metastasis.微小 RNA 在激素癌转移中的作用。
Mol Cell Endocrinol. 2017 Nov 15;456:62-75. doi: 10.1016/j.mce.2017.03.015. Epub 2017 Mar 18.

引用本文的文献

1
Noncoding RNA (ncRNA)-mediated regulation of TLRs: critical regulator of inflammation in tumor microenvironment.非编码RNA(ncRNA)介导的Toll样受体(TLR)调控:肿瘤微环境中炎症的关键调节因子
Med Oncol. 2025 Mar 31;42(5):144. doi: 10.1007/s12032-025-02690-9.
2
RNA-Sequence Reveals the Regulatory Mechanism of miR-149 on Osteoblast Skeleton under Mechanical Tension.RNA测序揭示机械张力下miR-149对成骨细胞骨架的调控机制
Stem Cells Int. 2022 Sep 23;2022:9640878. doi: 10.1155/2022/9640878. eCollection 2022.
3
DNA methyltransferase 3 beta regulates promoter methylation of microRNA-149 to augment esophageal squamous cell carcinoma development through the ring finger protein 2/Wnt/β-catenin axis.
DNA 甲基转移酶 3β 通过调节 microRNA-149 的启动子甲基化,通过环状指蛋白 2/Wnt/β-连环蛋白轴增强食管鳞状细胞癌的发展。
Bioengineered. 2022 Feb;13(2):4010-4027. doi: 10.1080/21655979.2022.2031411.
4
The expression and clinical significance of miR-1226 in patients with periodontitis.miR-1226 在牙周炎患者中的表达及临床意义。
BMC Oral Health. 2021 Sep 30;21(1):487. doi: 10.1186/s12903-021-01855-y.
5
Aberrant expression of miR-483-5p in patients with asymptomatic carotid artery stenosis and its predictive value for cerebrovascular event occurrence.无症状性颈动脉狭窄患者中miR-483-5p的异常表达及其对脑血管事件发生的预测价值。
Exp Ther Med. 2021 Oct;22(4):1101. doi: 10.3892/etm.2021.10536. Epub 2021 Aug 2.
6
Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer.左旋布比卡因通过miR-489-3p/SLC7A11信号通路诱导胃癌细胞铁死亡
Front Pharmacol. 2021 Jun 9;12:681338. doi: 10.3389/fphar.2021.681338. eCollection 2021.
7
Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion.低表达的 miR-1273a 预示着结直肠癌预后不良,并促进肿瘤细胞增殖、迁移和侵袭。
Braz J Med Biol Res. 2021 Jan 8;54(2):e10394. doi: 10.1590/1414-431X202010394. eCollection 2021.
8
MicroRNA-149 is downregulated in Alzheimer's disease and inhibits β-amyloid accumulation and ameliorates neuronal viability through targeting BACE1.微小RNA-149在阿尔茨海默病中表达下调,通过靶向β-分泌酶1抑制β-淀粉样蛋白积累并改善神经元活力。
Genet Mol Biol. 2021 Jan 11;44(1):e20200064. doi: 10.1590/1678-4685-GMB-2020-0064. eCollection 2021.
9
MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway.MAP17 通过抑制 miR-27a-3p 的表达和 p38 信号通路促进非小细胞肺癌的进展。
Cancer Biol Ther. 2021 Jan 2;22(1):19-29. doi: 10.1080/15384047.2020.1836948. Epub 2020 Dec 7.
10
miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.miR-541 可作为骨肉瘤的预后生物标志物,通过靶向 TGIF2 调控骨肉瘤细胞的增殖、迁移和侵袭。
Diagn Pathol. 2020 Jul 24;15(1):96. doi: 10.1186/s13000-020-01008-9.